Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Clinical trial NCT00195533 · COMPLETED

Trial details

NCT number: NCT00195533
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Hematological Malignancy Leukemia Myelodysplasia Lymphoma Myeloma Stem Cell Transplantation

Start date: 2001-07-01
Primary completion: 2005-03-01
Enrollment: 801

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.